Resveratrol in cancer management: where are we and where we go from here?
about
Plant-derived anti-inflammatory compounds: hopes and disappointments regarding the translation of preclinical knowledge into clinical progressRedefining the impact of nutrition on breast cancer incidence: is epigenetics involved?Resveratrol and cancer: Challenges for clinical translationNutritional countermeasures targeting reactive oxygen species in cancer: from mechanisms to biomarkers and clinical evidenceResveratrol as a pan-HDAC inhibitor alters the acetylation status of histone [corrected] proteins in human-derived hepatoblastoma cellsRisk of upper aerodigestive tract cancer and type of alcoholic beverage: a European multicenter case-control study.Resveratrol: review on therapeutic potential and recent advances in drug delivery.Dietary grape polyphenol resveratrol increases mammary tumor growth and metastasis in immunocompromised mice.The interaction between epigenetics, nutrition and the development of cancerEnhancing the bioavailability of resveratrol by combining it with piperineAntitumor activity of melinjo (Gnetum gnemon L.) seed extract in human and murine tumor models in vitro and in a colon-26 tumor-bearing mouse model in vivo.Chemoprevention of benzo(a)pyrene-induced colon polyps in ApcMin mice by resveratrolResveratrol promotes regression of renal carcinoma cells via a renin-angiotensin system suppression-dependent mechanism.3,4,5,4'-trans-tetramethoxystilbene (DMU-212) modulates the activation of NF-κB, AP-1, and STAT3 transcription factors in rat liver carcinogenesis induced by initiation-promotion regimen.The grape antioxidant resveratrol for skin disorders: promise, prospects, and challenges.Resveratrol and health--a comprehensive review of human clinical trials.Bioavailability of phytochemicals and its enhancement by drug delivery systems.Resveratrol-based combinatorial strategies for cancer management.The effect of resveratrol and its methylthio-derivatives on EGFR and Stat3 activation in human HaCaT and A431 cells.Evaluation of resveratrol sensitivities and metabolic patterns in human and rat glioblastoma cells.Differential effects of resveratrol and its natural analogs, piceatannol and 3,5,4'-trans-trimethoxystilbene, on anti-inflammatory heme oxigenase-1 expression in RAW264.7 macrophages.Addressing Facts and Gaps in the Phenolics Chemistry of Winery By-Products.Cancer Chemoprevention by Resveratrol: The p53 Tumor Suppressor Protein as a Promising Molecular Target.Resveratrol derivatives as a pharmacological tool.Plant phytochemicals as new potential drugs for immune disorders and cancer therapy: really a promising path?Pterostilbene simultaneously induces apoptosis, cell cycle arrest and cyto-protective autophagy in breast cancer cells.Physical and Pharmacokinetic Characterizations of trans-Resveratrol (t-Rev) Encapsulated with Self-Assembling Lecithin-based Mixed Polymeric Micelles (saLMPMs)Piperine potentiates the antidepressant-like effect of trans-resveratrol: involvement of monoaminergic system.Resveratrol Role in Autoimmune Disease-A Mini-Review.Preparation and in-vitro/in-vivo characterization of trans-resveratrol nanocrystals for oral administration.
P2860
Q21284734-D8B13739-2DD3-4A28-81B0-A4E8A420F7C4Q27011732-9EBA6C41-877B-4124-A7B1-02C5BB3F0BAAQ27015712-FE52DAA0-84FC-489F-8CB6-8081DCF350F9Q28393187-85EF2492-D4F6-41FA-BBDE-54B869EFF5B6Q28536197-24C32F25-0444-49A9-B97F-164FB053A01DQ34280936-5430EA48-1535-4172-8548-BDA32F017DF6Q34420121-A847A7E9-328F-43B3-9402-EE43EC44D9D3Q34539310-12B6D6BD-EE4F-420D-A93F-D919E1473460Q35131323-FF0FCCBD-328A-4D99-8C76-1C84772FFBC6Q35807346-309F4848-1709-4BD3-A98E-A33E05B6A38FQ36358601-4606190A-6D81-41B2-BFDE-696C53D516E3Q36403593-43435D57-366E-4D48-ABEF-47E6A6B1F6C7Q37700988-737610A9-4A5F-4C79-A804-1CECFE8831E6Q37735173-5DBEAC60-3DF4-4DEA-B3DB-6E4C1BECF4AFQ37826817-23E97228-CCA5-46E1-B02A-B4E763718EF7Q37891928-E28A6453-F93A-41D8-94BE-1FA588D8D590Q38084084-24B253FE-E8CE-402E-AD1F-5B6966E32EA2Q38121604-0374AC5A-81FD-4165-A17D-A84C628AA925Q38971568-3FB1A9F5-E924-4D28-9562-9B6F32908746Q39103076-2A208646-2228-4E0D-831F-9096D7E56E29Q39124882-B9F28A65-872D-4908-BAE2-1CF0520FF231Q39143318-080BA371-5495-42A5-817C-03C703B9EAFDQ39383463-B067EF29-2BE0-4350-BC4B-77FBD31ACF19Q39413479-C3D7123A-9069-438F-B784-C4DD47FEA585Q39633051-8FBDDB33-A68A-44DB-ACB2-B71E11D2C494Q40985517-140C3AB3-9743-44F4-93BD-C25D0395D901Q41629561-62338DAB-5B0C-4061-9F64-0B760760BD88Q42709861-BA1A49B2-2264-4DD4-BE2E-996AC10CC769Q47158536-5F17DBF7-958E-4E44-BB98-BE5CD1DDB67CQ52790753-993F2CBA-598B-4FBB-A60B-A23514C0418E
P2860
Resveratrol in cancer management: where are we and where we go from here?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Resveratrol in cancer management: where are we and where we go from here?
@en
Resveratrol in cancer management: where are we and where we go from here?
@nl
type
label
Resveratrol in cancer management: where are we and where we go from here?
@en
Resveratrol in cancer management: where are we and where we go from here?
@nl
prefLabel
Resveratrol in cancer management: where are we and where we go from here?
@en
Resveratrol in cancer management: where are we and where we go from here?
@nl
P2093
P2860
P1476
Resveratrol in cancer management: where are we and where we go from here?
@en
P2093
Mary Ndiaye
Nihal Ahmad
P2860
P304
P356
10.1111/J.1749-6632.2010.05851.X
P407
P577
2011-01-01T00:00:00Z